3DPrint.com August 28, 2024
Vanesa Listek

Five years have passed since we first mapped the world of bioprinting, and in that time, the landscape has dramatically shifted. In 2019, bioprinting was a sector focused on the ambitious potential of 3D printed organs, tissues, and human implantation—goals that remain on the horizon but are now complemented by a pivot toward more immediate, practical applications.

The journey from 2019 to 2024, as tracked and analyzed by 3DPrint.com, has seen approximately 30% of the 119 companies that initially staked their claim in the bioprinting sector either close, get acquired, or move away from any bioprinting activity. But in their wake, 58 new companies have emerged, and some of the original players have not only survived but thrived by narrowing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, Technology
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article